1 Opthalmic Pharmaceutical Drugs Market Overview 1.1 Product Overview and Scope of Opthalmic Pharmaceutical Drugs 1.2 Opthalmic Pharmaceutical Drugs Segment by Type 1.2.1 Global Opthalmic Pharmaceutical Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Anti-glaucoma 1.2.3 Anti-infection 1.2.4 Anti-inflammatory 1.2.5 Anti-allergy 1.3 Opthalmic Pharmaceutical Drugs Segment by Application 1.3.1 Global Opthalmic Pharmaceutical Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Online Pharmacies 1.3.5 Others 1.4 Global Opthalmic Pharmaceutical Drugs Market Size Estimates and Forecasts 1.4.1 Global Opthalmic Pharmaceutical Drugs Revenue 2017-2028 1.4.2 Global Opthalmic Pharmaceutical Drugs Sales 2017-2028 1.4.3 Opthalmic Pharmaceutical Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Opthalmic Pharmaceutical Drugs Market Competition by Manufacturers 2.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Opthalmic Pharmaceutical Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Opthalmic Pharmaceutical Drugs Manufacturing Sites, Area Served, Product Type 2.5 Opthalmic Pharmaceutical Drugs Market Competitive Situation and Trends 2.5.1 Opthalmic Pharmaceutical Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Opthalmic Pharmaceutical Drugs Players Market Share by Revenue 2.5.3 Global Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Opthalmic Pharmaceutical Drugs Retrospective Market Scenario by Region 3.1 Global Opthalmic Pharmaceutical Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Opthalmic Pharmaceutical Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country 3.3.1 North America Opthalmic Pharmaceutical Drugs Sales by Country 3.3.2 North America Opthalmic Pharmaceutical Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country 3.4.1 Europe Opthalmic Pharmaceutical Drugs Sales by Country 3.4.2 Europe Opthalmic Pharmaceutical Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Opthalmic Pharmaceutical Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region 3.5.2 Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country 3.6.1 Latin America Opthalmic Pharmaceutical Drugs Sales by Country 3.6.2 Latin America Opthalmic Pharmaceutical Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country 3.7.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Opthalmic Pharmaceutical Drugs Historic Market Analysis by Type 4.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2022) 4.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Opthalmic Pharmaceutical Drugs Price by Type (2017-2022) 5 Global Opthalmic Pharmaceutical Drugs Historic Market Analysis by Application 5.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2022) 5.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Opthalmic Pharmaceutical Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Johnson & Johnson 6.1.1 Johnson & Johnson Corporation Information 6.1.2 Johnson & Johnson Description and Business Overview 6.1.3 Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Portfolio 6.1.5 Johnson & Johnson Recent Developments/Updates 6.2 Carl-Zeiss 6.2.1 Carl-Zeiss Corporation Information 6.2.2 Carl-Zeiss Description and Business Overview 6.2.3 Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Portfolio 6.2.5 Carl-Zeiss Recent Developments/Updates 6.3 Ellex Medical Lasers 6.3.1 Ellex Medical Lasers Corporation Information 6.3.2 Ellex Medical Lasers Description and Business Overview 6.3.3 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Portfolio 6.3.5 Ellex Medical Lasers Recent Developments/Updates 6.4 Essilor International 6.4.1 Essilor International Corporation Information 6.4.2 Essilor International Description and Business Overview 6.4.3 Essilor International Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Essilor International Opthalmic Pharmaceutical Drugs Product Portfolio 6.4.5 Essilor International Recent Developments/Updates 6.5 Hoya Corporation 6.5.1 Hoya Corporation Corporation Information 6.5.2 Hoya Corporation Description and Business Overview 6.5.3 Hoya Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Hoya Corporation Opthalmic Pharmaceutical Drugs Product Portfolio 6.5.5 Hoya Corporation Recent Developments/Updates 6.6 Insight Vision 6.6.1 Insight Vision Corporation Information 6.6.2 Insight Vision Description and Business Overview 6.6.3 Insight Vision Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Insight Vision Opthalmic Pharmaceutical Drugs Product Portfolio 6.6.5 Insight Vision Recent Developments/Updates 6.7 Nidek 6.6.1 Nidek Corporation Information 6.6.2 Nidek Description and Business Overview 6.6.3 Nidek Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Nidek Opthalmic Pharmaceutical Drugs Product Portfolio 6.7.5 Nidek Recent Developments/Updates 6.8 Novagali Pharma 6.8.1 Novagali Pharma Corporation Information 6.8.2 Novagali Pharma Description and Business Overview 6.8.3 Novagali Pharma Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Novagali Pharma Opthalmic Pharmaceutical Drugs Product Portfolio 6.8.5 Novagali Pharma Recent Developments/Updates 6.9 Topcon Corporation 6.9.1 Topcon Corporation Corporation Information 6.9.2 Topcon Corporation Description and Business Overview 6.9.3 Topcon Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Topcon Corporation Opthalmic Pharmaceutical Drugs Product Portfolio 6.9.5 Topcon Corporation Recent Developments/Updates 6.10 Ziemer Ophthalmic Systems 6.10.1 Ziemer Ophthalmic Systems Corporation Information 6.10.2 Ziemer Ophthalmic Systems Description and Business Overview 6.10.3 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Portfolio 6.10.5 Ziemer Ophthalmic Systems Recent Developments/Updates 7 Opthalmic Pharmaceutical Drugs Manufacturing Cost Analysis 7.1 Opthalmic Pharmaceutical Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Opthalmic Pharmaceutical Drugs 7.4 Opthalmic Pharmaceutical Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Opthalmic Pharmaceutical Drugs Distributors List 8.3 Opthalmic Pharmaceutical Drugs Customers 9 Opthalmic Pharmaceutical Drugs Market Dynamics 9.1 Opthalmic Pharmaceutical Drugs Industry Trends 9.2 Opthalmic Pharmaceutical Drugs Market Drivers 9.3 Opthalmic Pharmaceutical Drugs Market Challenges 9.4 Opthalmic Pharmaceutical Drugs Market Restraints 10 Global Market Forecast 10.1 Opthalmic Pharmaceutical Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Opthalmic Pharmaceutical Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Opthalmic Pharmaceutical Drugs by Type (2023-2028) 10.2 Opthalmic Pharmaceutical Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Opthalmic Pharmaceutical Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Opthalmic Pharmaceutical Drugs by Application (2023-2028) 10.3 Opthalmic Pharmaceutical Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Opthalmic Pharmaceutical Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Opthalmic Pharmaceutical Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Opthalmic Pharmaceutical Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Opthalmic Pharmaceutical Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Opthalmic Pharmaceutical Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Opthalmic Pharmaceutical Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Opthalmic Pharmaceutical Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Opthalmic Pharmaceutical Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Opthalmic Pharmaceutical Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Opthalmic Pharmaceutical Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Opthalmic Pharmaceutical Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Opthalmic Pharmaceutical Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opthalmic Pharmaceutical Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Opthalmic Pharmaceutical Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2017-2022) Table 17. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2017-2022) Table 21. North America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Opthalmic Pharmaceutical Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2017-2022) Table 41. Global Opthalmic Pharmaceutical Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Opthalmic Pharmaceutical Drugs Revenue Share by Type (2017-2022) Table 43. Global Opthalmic Pharmaceutical Drugs Price by Type (2017-2022) & (USD/Unit) Table 44. Global Opthalmic Pharmaceutical Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2017-2022) Table 46. Global Opthalmic Pharmaceutical Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Opthalmic Pharmaceutical Drugs Revenue Share by Application (2017-2022) Table 48. Global Opthalmic Pharmaceutical Drugs Price by Application (2017-2022) & (USD/Unit) Table 49. Johnson & Johnson Corporation Information Table 50. Johnson & Johnson Description and Business Overview Table 51. Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Table 53. Johnson & Johnson Recent Developments/Updates Table 54. Carl-Zeiss Corporation Information Table 55. Carl-Zeiss Description and Business Overview Table 56. Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Table 58. Carl-Zeiss Recent Developments/Updates Table 59. Ellex Medical Lasers Corporation Information Table 60. Ellex Medical Lasers Description and Business Overview Table 61. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Table 63. Ellex Medical Lasers Recent Developments/Updates Table 64. Essilor International Corporation Information Table 65. Essilor International Description and Business Overview Table 66. Essilor International Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Essilor International Opthalmic Pharmaceutical Drugs Product Table 68. Essilor International Recent Developments/Updates Table 69. Hoya Corporation Corporation Information Table 70. Hoya Corporation Description and Business Overview Table 71. Hoya Corporation Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Hoya Corporation Opthalmic Pharmaceutical Drugs Product Table 73. Hoya Corporation Recent Developments/Updates Table 74. Insight Vision Corporation Information Table 75. Insight Vision Description and Business Overview Table 76. Insight Vision Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Insight Vision Opthalmic Pharmaceutical Drugs Product Table 78. Insight Vision Recent Developments/Updates Table 79. Nidek Corporation Information Table 80. Nidek Description and Business Overview Table 81. Nidek Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Nidek Opthalmic Pharmaceutical Drugs Product Table 83. Nidek Recent Developments/Updates Table 84. Novagali Pharma Corporation Information Table 85. Novagali Pharma Description and Business Overview Table 86. Novagali Pharma Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Novagali Pharma Opthalmic Pharmaceutical Drugs Product Table 88. Novagali Pharma Recent Developments/Updates Table 89. Topcon Corporation Corporation Information Table 90. Topcon Corporation Description and Business Overview Table 91. Topcon Corporation Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Topcon Corporation Opthalmic Pharmaceutical Drugs Product Table 93. Topcon Corporation Recent Developments/Updates Table 94. Ziemer Ophthalmic Systems Corporation Information Table 95. Ziemer Ophthalmic Systems Description and Business Overview Table 96. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Table 98. Ziemer Ophthalmic Systems Recent Developments/Updates Table 99. Production Base and Market Concentration Rate of Raw Material Table 100. Key Suppliers of Raw Materials Table 101. Opthalmic Pharmaceutical Drugs Distributors List Table 102. Opthalmic Pharmaceutical Drugs Customers List Table 103. Opthalmic Pharmaceutical Drugs Market Trends Table 104. Opthalmic Pharmaceutical Drugs Market Drivers Table 105. Opthalmic Pharmaceutical Drugs Market Challenges Table 106. Opthalmic Pharmaceutical Drugs Market Restraints Table 107. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 108. Global Opthalmic Pharmaceutical Drugs Sales Market Share Forecast by Type (2023-2028) Table 109. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 110. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Type (2023-2028) Table 111. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 112. Global Opthalmic Pharmaceutical Drugs Sales Market Share Forecast by Application (2023-2028) Table 113. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 114. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Application (2023-2028) Table 115. Global Opthalmic Pharmaceutical Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 116. Global Opthalmic Pharmaceutical Drugs Sales Market Share Forecast by Region (2023-2028) Table 117. Global Opthalmic Pharmaceutical Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 118. Global Opthalmic Pharmaceutical Drugs Revenue Market Share Forecast by Region (2023-2028) Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Opthalmic Pharmaceutical Drugs Figure 2. Global Opthalmic Pharmaceutical Drugs Market Share by Type in 2021 & 2028 Figure 3. Anti-glaucoma Product Picture Figure 4. Anti-infection Product Picture Figure 5. Anti-inflammatory Product Picture Figure 6. Anti-allergy Product Picture Figure 7. Global Opthalmic Pharmaceutical Drugs Market Share by Application in 2021 & 2028 Figure 8. Hospital Pharmacies Figure 9. Drug Stores Figure 10. Online Pharmacies Figure 11. Others Figure 12. Global Opthalmic Pharmaceutical Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Opthalmic Pharmaceutical Drugs Market Size (2017-2028) & (US$ Million) Figure 14. Global Opthalmic Pharmaceutical Drugs Sales (2017-2028) & (K Units) Figure 15. Opthalmic Pharmaceutical Drugs Sales Share by Manufacturers in 2021 Figure 16. Global Opthalmic Pharmaceutical Drugs Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Opthalmic Pharmaceutical Drugs Players: Market Share by Revenue in 2021 Figure 18. Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2017-2022) Figure 20. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region in 2021 Figure 21. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2017-2022) Figure 22. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region in 2021 Figure 23. U.S. Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Taiwan Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Philippines Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Vietnam Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Mexico Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Brazil Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Argentina Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Turkey Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Saudi Arabia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. U.A.E Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. Sales Market Share of Opthalmic Pharmaceutical Drugs by Type (2017-2022) Figure 48. Manufacturing Cost Structure of Opthalmic Pharmaceutical Drugs Figure 49. Manufacturing Process Analysis of Opthalmic Pharmaceutical Drugs Figure 50. Opthalmic Pharmaceutical Drugs Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Johnson & Johnson Carl-Zeiss Ellex Medical Lasers Essilor International Hoya Corporation Insight Vision Nidek Novagali Pharma Topcon Corporation Ziemer Ophthalmic Systems